CO – The Colorado
State University announced a new program to move infectious-disease
research to market faster than its existing technology transfer models.
A non-profit entity called MicroRx will create “superclusters”
of academic researchers, economists and business people to gauge the
marketability of research in process. Acting
as a “triage”, the groups will encourage scientists with promising research to
begin working with business people as early in the process as possible.
MicroRx operating revenues are expected to come from patents,
licensing agreements, start up companies and partnerships that come out of university
research collaboration. The current
budget for the program tops $1 million.